Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRenovoRx Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.09 | -$0.07 | -$0.08 |
| Q2 2026 | 2 | -$0.08 | -$0.07 | -$0.08 |
| Q3 2026 | 1 | -$0.11 | -$0.03 | -$0.07 |
| Q4 2026 | 1 | -$0.11 | -$0.03 | -$0.07 |
| Q1 2027 | 1 | -$0.10 | -$0.03 | -$0.06 |
| Q2 2027 | 1 | -$0.10 | -$0.03 | -$0.06 |
| Q3 2027 | 1 | -$0.10 | -$0.03 | -$0.06 |
| Q4 2027 | 1 | -$0.08 | -$0.02 | -$0.05 |
RenovoRx Inc Earnings Date And Information
RenovoRx Inc last posted its earnings results on Monday, March 30th, 2026. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0. The company had revenue of 238.00 K for the quarter and had revenue of 1.12 M for the year. RenovoRx Inc has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -2.83. RenovoRx Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
RenovoRx Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q4 2025 | -$0.08 | -$0.08 | -0 | $419.70 K | $238.00 K |
| 11/13/2025 | Q3 2025 | -$0.08 | -$0.08 | 0 | $405.40 K | $266.00 K |
| 08/14/2025 | Q2 2025 | -$0.08 | -$0.08 | 0 | $329.63 K | $422.00 K |
| 05/15/2025 | Q1 2025 | -$0.08 | -$0.08 | 0 | $183.33 K | $197.00 K |
| 03/31/2025 | Q4 2024 | N/A | -$0.13 | N/A | N/A | $43.00 K |
| 11/13/2024 | Q3 2024 | -$0.12 | -$0.10 | 0.02 | N/A | $0 |
| 08/13/2024 | Q2 2024 | -$0.10 | -$0.10 | 0 | N/A | $0 |
| 05/10/2024 | Q1 2024 | -$0.14 | -$0.04 | 0.1 | N/A | $0 |
| 04/01/2024 | Q4 2023 | -$0.30 | -$0.15 | 0.15 | N/A | $0 |
| 11/13/2023 | Q3 2023 | -$0.30 | -$0.07 | 0.23 | N/A | $0 |
| 08/16/2023 | Q2 2023 | -$0.25 | -$0.11 | 0.14 | N/A | $0 |
| 05/12/2023 | Q1 2023 | N/A | -$0.18 | N/A | N/A | $0 |
| 03/31/2023 | Q4 2022 | N/A | -$0.11 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$0.27 | -$0.12 | 0.15 | N/A | $0 |
| 08/12/2022 | Q2 2022 | N/A | -$0.14 | N/A | N/A | $0 |
| 05/13/2022 | Q1 2022 | N/A | -$0.17 | N/A | N/A | $0 |
| 03/30/2022 | Q4 2021 | -$0.18 | -$0.21 | -0.03 | N/A | $0 |
| 11/15/2021 | Q3 2021 | -$0.21 | -$0.13 | 0.08 | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$0.08 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.07 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
RenovoRx Inc Earnings: FAQ's
The conference call for RenovoRx Inc's latest earnings report can be listened to online.
The conference call transcript for RenovoRx Inc's latest earnings report can be read online.
RenovoRx Inc (:RNXT) has a recorded annual revenue of $1.12 M.
RenovoRx Inc (:RNXT) has a recorded net income of $-11,168,000.RenovoRx Inc has generated $-0.32 earnings per share over the last four quarters.
RenovoRx Inc (:RNXT) has a price-to-earnings ratio of -2.83 and price/earnings-to-growth ratio is -0.36.